1. Home
  2. SLI vs EVO Comparison

SLI vs EVO Comparison

Compare SLI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard Lithium Ltd.

SLI

Standard Lithium Ltd.

HOLD

Current Price

$3.84

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.69

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLI
EVO
Founded
1998
1993
Country
Canada
Germany
Employees
N/A
4553
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
934.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SLI
EVO
Price
$3.84
$2.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$5.25
$7.00
AVG Volume (30 Days)
1.8M
94.1K
Earning Date
05-11-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.49
$2.31
52 Week High
$6.40
$4.80

Technical Indicators

Market Signals
Indicator
SLI
EVO
Relative Strength Index (RSI) 48.41 36.25
Support Level $3.04 $2.32
Resistance Level $4.08 $3.78
Average True Range (ATR) 0.23 0.09
MACD 0.01 -0.06
Stochastic Oscillator 27.33 6.44

Price Performance

Historical Comparison
SLI
EVO

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company the company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: